11 NOVEMBER 2026, WEDNESDAY
| Time | 09:30 – 16:00 (GMT+8) | |||
| Venue | Grand Hyatt Singapore, Residence 6, Level 3 | |||
| Format | Rotating hands-on stations with focused short didactic sessions and practical demonstrations | |||
| Introduction | This hands-on workshop is designed to strengthen both the technical execution and clinical reasoning required for advanced bronchoscopy and interventional pulmonology. Each station combines short expert demonstrations with deliberate practice, troubleshooting, and discussion of indications, safety checks, and complication management | |||
| Objectives | – Develop a structured approach to procedure planning, including indication, airway anatomy, lesion or nodal target, device selection, and rescue strategy.
– Improve hands-on familiarity with convex-probe EBUS bronchoscopes, R-EBUS probes, guide sheaths, biopsy tools, cryoprobes, ablative devices, rigid bronchoscopes, and airway stents. – Practice stepwise technical execution with attention to ergonomics, team communication, equipment readiness, and procedural flow. – Recognise pitfalls early and apply practical strategies for bleeding, airway obstruction, pneumothorax risk, device malposition, and loss of target access.
|
|||
| Target Participants | Respiratory physicians, interventional pulmonologists, thoracic surgeons, respiratory and thoracic fellows and trainees, intensivists with an interest in advanced bronchoscopy, bronchoscopy nurses, and allied healthcare professionals involved in bronchoscopy services. | |||
| Participants Number | 30 pax | |||
| Lead Faculty | Melvin Tay C.K. | |||
| Faculty |
Phan Nguyen
Australia Wang Hai
China Hari Kishan Gonuguntla
India Eric D. Tenda
Indonesia Khai Lip Ng
Malaysia Kho Sze Shyang
Malaysia Ronald Fajardo
Philippines Brian Chua L W
Singapore Clare Fong
Singapore Carrie Leong
Singapore Eugene Gan
Singapore Lee Pyng
Singapore Melvin Tay C.K.
Singapore Sean Loh
Singapore Thitiwat S.
Thailand |
|||
| Cost per pax |
Bronchoscopy Workshop (11 Nov) USD 150 / SGD 190
Register for both workshops at a special bundle rate of USD 300 / SGD 380. |
|||
| Registration | This Workshop is available as an add-on to the Main Congress. Click here to register. | |||
Station Map
| Station | Technical focus | Primary skills | Knowledge emphasis |
| 1 | Radial EBUS-Guided Peripheral Lung Biopsy | REBUS + thin scope +/- guide sheath + reusable guiding device; REBUS + ultrathin scope + peripheral TBNA | Lesion localization, airway-pathway planning, guide-sheath technique, peripheral TBNA integration, specimen acquisition, and complication management. |
| 2 | Transbronchial Lung Cryobiopsy | Cryobiopsy + therapeutic scope; Cryobiopsy + thin scope | Technical execution, workflow integration, fluoroscopy/REBUS-assisted localization, prophylactic balloon use, sample handling, and safety management. |
| 3 | Mediastinal Lymph Node Biopsy: Beyond Standard TBNA | Intranodal forceps biopsy; Cryonodal biopsy | Indications, nodal targeting, EBUS-TBNA setup, intranodal forceps biopsy, cryonodal biopsy, and safety considerations. |
| 4 | Principles of Rigid Bronchoscopy | Rigid bronchoscopy | Rigid intubation, airway alignment, scope handling, telescope use, ventilation considerations, and procedural caution. |
| 5 | Bronchoscopic Ablative Therapies: Expert Tips and Pitfalls | APC / electrocautery; Cryotherapy | Principles, indications, energy delivery, tissue effects, airway fire prevention, and complications for APC, electrocautery, and cryotherapy. |
| 6 | Silicone and Metallic Airway Stent Placement | Metallic airway stent placement; Silicone airway stent placement | Device selection, airway sizing, deployment strategy, troubleshooting, and complication management for malignant and benign airway obstruction. |
Since 1937, Ambu has been rethinking solutions, together with healthcare professionals, to save lives and improve patient care. Today, millions of patients and healthcare professionals worldwide depend on the efficiency, safety, and performance of our single-use endoscopy, anaesthesia, and patient monitoring solutions.
We are driven by our strong purpose: Together, we rethink solutions to save lives and improve patient care.
Working with Sustainability: The Ambu Way
For more information, please visit www.ambu.com
First Pharmaceutical Sdn Bhd is a pharmaceutical product distributor in Malaysia. In 1987, We established as the subsidiary company of Kyowa Hakko Kogyo Co. Ltd and Sole Distributor for DAIICHI Pharmaceutical Co. Ltd. For almost 35 years, we have built an effective and extensive pharmaceutical distribution network throughout Malaysia for a range of global partners. First Pharmaceutical is one of the local pharmaceutical companies involved in prescription drugs such as antibiotics, anti-cancer agents and OTC products to every hospital, general practitioner and pharmacy throughout Malaysia. We will strive to provide our best services and distribute good quality products throughout whole Malaysia. Our global partners include Daiichi Pharmaceutical Co. Ltd., Kyowa Kirin, Pro.Med.cs Praha a.s, Korea United Pharm Inc., DaeHan NewPharm, JW holding, SeaCross Pharmaceuticals, Laboratoire Aguettant, Medac Gmbh, and etc.
For more information, please visit www.firstpharma.com.my
GE HealthCare Technologies Inc. is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine to help clinicians deliver more personalised, precise patient care. This is complemented by our broad service capabilities and dedication to quality and integrity with a strong operational culture, supported by our lean business system, Heartbeat.
For more information, please visit www.gehealthcare.com/en-sg
At Olympus, our Purpose is to make people’s lives healthier, safer, and more fulfilling. For more than 100 years, we have partnered with healthcare professionals to advance medical technology and deliver solutions that support early detection, accurate diagnosis, and minimally invasive treatment.
Our commitment to improving patient care is reflected in our continued investment in clinically advanced, precision technologies and services. In respiratory care, we are passionate about supporting healthcare professionals in the diagnosis and management of lung disease, particularly lung cancer, where early and accurate diagnosis can make a meaningful difference to patient outcomes.
Through our comprehensive portfolio of minimally invasive respiratory and lung cancer solutions, Olympus strives to help clinicians visualize, diagnose, and treat disease with greater confidence. By combining clinical expertise with innovative technology, we aim to elevate the standard of care and contribute to better outcomes for patients today and into the future.
For more information, please visit www.olympus-global.com/apac
| Time | 08:30 – 16:30 (GMT+8) | |||
| Venue | Grand Hyatt Singapore, Residence 2, Level 3 | |||
| Title | Nursing Workshop / Contemporary Thoracic Nursing: From Robotics to Chest Drain Mastery | |||
| Format | Highly interactive workshop featuring lectures, demonstrations, hands-on skills stations, dry-lab practice, case-based discussions, and rotating small-group learning activities. | |||
| Introduction | A practical nursing workshop focused on contemporary thoracic care. The programme brings together robotics and surgical technology, chest drain management, and chest drain dressing and securement through lectures, demonstrations, station rotations, hands-on practice and facilitated case discussion. | |||
| Objectives | – Describe nursing roles, workflow and safety considerations in robotic thoracic surgery.
– Explore emerging surgical technologies and their translation from innovation to clinical practice. – Compare conventional and digital chest drainage systems, including their indications, set-up and safety principles. – Demonstrate safe chest drain assembly, monitoring, troubleshooting, dressing and securement techniques. – Apply learning to common clinical scenarios, escalation needs and patient education. |
|||
| Target Participants | Thoracic nurses, Respiratory nurses, Operating theatre nurses, Advanced Practice Nurses (APNs), and other nursing professionals involved in thoracic surgical and respiratory care. | |||
| Participants Number | 50 pax | |||
| Lead Faculty | Doreen Chew | |||
| Faculty | Jonie Lim
Senbagam D/O Sivaramakrishnan Xiao Li |
|||
| Registration | This Workshop is complimentary with Main Congress registration. Click here to register for the Main Congress. | |||
Programme
| Time | Agenda | Faculty |
| 08:00 – 10:30 | Session 1: Robotics and Technology in Thoracic Nursing – What Every Thoracic Nurse Should Know | All Faculty |
| 08:00 – 08:45 | OR Workflow and Safety | |
| 09:00 – 10:30 | Demo on Robotics and Technology in Thoracic Nursing | |
| 10:00 – 10:30 | Coffee/Tea Break | |
| 10:30 – 12:00 | Session 2: Emerging Surgical Technologies: From Innovation to Clinical Practice |
All Faculty |
| 10:30 – 10:42 | Coming Soon | |
| 10:42 – 10:54 | ||
| 10:54 – 11:06 | ||
| 11:06 – 11:18 | ||
| 11:18 – 11:30 | ||
| 11:30 – 11:42 | ||
| 11:42 – 12:00 | ||
| 12:00 – 13:00 | Lunch Break | |
| 13:30 – 15:30 | Session 3: Contemporary Chest Drain Management: Evidence, Technology and Best Practice | All Faculty |
| 13:30 – 14:00 | System Fundamentals | |
| 14:00 – 15:30 | Demo on Contemporary Chest Drain Management | |
| 14:30 – 15:00 | Coffee/Tea Break | |
| 15:30 – 17:00 | Session 4: Chest Drain Dressing and Securement: From Evidence to Practice |
All Faculty |
| 15:30 – 16:15 | Evidence and Technique | |
| 16:15 – 17:00 | Demo on Sterile Dressing and Securement |
Since 1992, Device Technologies has been dedicated to improving patients lives through leading edge technology and services.
Successfully supplying hospitals and healthcare professionals with the finest medical solutions for their patients, Device Technologies continues to grow, with over 200 trusted brands and 850 highly skilled staff Australia and New Zealand-wide. Since 2019, Device Technologies has expanded its footprint into Asia, establishing offices in Singapore, Malaysia, Thailand, Vietnam, Philippines and Indonesia.
Leading the way in the medical technology field, Device Technologies provides the highest calibre of medical supplies with innovation and client care at the core of its values. All products distributed by Device Technologies are compliant with quality regulatory requirements, with in-servicing and ongoing support provided as part of the trusted partnership between Device Technologies staff and healthcare professionals.
For more information, please visit www.devicetechnologies.asia
At SEATS 2026, Equip Medical Pte Ltd is proud to exhibit alongside our partner Medela AG, bringing the Thopaz+ Digital Chest Drainage System to Singapore’s thoracic surgery, pulmonology, and oncology community.
Since 1986, Equip Medical Pte Ltd has been one of Singapore’s leading medical equipment distributors, serving major hospitals and healthcare institutions across Singapore, Malaysia, and Thailand. As the local partner for Medela’s surgical and critical care portfolio, we bring not only product access but also on-the-ground clinical support, technical service, and long-term equipment lifecycle management, ensuring that the technology we distribute continues to perform reliably long after installation.
Medela’s Thopaz+ system represents a shift from analogue chest drainage toward objective, digital patient management. Unlike traditional analogue systems that rely on visual interpretation of bubbling and fluid columns, Thopaz+ uses digital technology to apply and maintain consistent, regulated negative pressure while continuously monitoring air leak and fluid drainage in real time. It is used across cardiothoracic surgery, thoracic surgery, trauma care, paediatrics, and ICU/HDU settings, and supports Enhanced Recovery After Surgery (ERAS) protocols through reduced chest tube duration, improved patient mobility, and fewer complications. The system is backed by more than 65 published studies covering over 9,000 patients, and is used to treat more than 530,000 patients globally each year.
Together, Equip Medical Pte Ltd and Medela a Swiss Company are committed to supporting thoracic surgeons and multidisciplinary care teams across the region with technology that translates directly into better, faster, and safer patient recovery.
We invite delegates to visit our booth to see Thopaz+ in action and discuss how digital chest drainage can support your unit’s ERAS and post-operative care pathways.
For more information, please visit www.equipmedical.com.sg
I:Emedics Pte Ltd is a medical device distributor based in Singapore, established in 2005. With a focus on Anaesthesiology, ENT, Respiratory, and Wound Care products, we are committed to providing high-quality medical devices to the healthcare industry in Singapore.
Our mission is to make a difference in people’s lives by providing innovative medical products that improve patient outcomes. We work with leading manufacturers worldwide to bring the latest medical technology to healthcare professionals in Singapore.
At I:Emedics, we pride ourselves on our commitment to customer service. We work closely with our customers to understand their needs and provide customized solutions that meet their unique requirements. Our team of experienced professionals is dedicated to providing exceptional service and support, from product training to technical assistance and after-sales service.
For more information, please visit www.iemedics.com
Perfusion Services & Supplies Pte Ltd (PSS) is a Singapore-based medical device company dedicated to advancing cardiac surgery, perfusion, critical care and innovative patient-care solutions across Singapore and the region.
With a strong foundation in cardiovascular medicine, PSS works closely with hospitals, cardiac surgeons, perfusionists, anaesthesiologists and other healthcare professionals to introduce innovative medical technologies that address evolving clinical needs and improve patient outcomes.
Our portfolio encompasses specialised solutions for cardiopulmonary bypass and perfusion, cardiac surgery, blood management, haemoadsorption therapy, post-operative pain management and other advanced cardiovascular applications. Beyond supplying medical technologies, PSS places significant emphasis on clinical education, technical support and the responsible adoption of new therapies.
We believe that successful healthcare partnerships extend beyond products. Through close collaboration with our international manufacturing partners and local clinical teams, we facilitate training, clinical exchanges, workshops and educational programmes that enable healthcare professionals to share knowledge and experience across institutions and countries.
Headquartered in Singapore, PSS continues to expand its presence and partnerships within Southeast Asia while maintaining a strong commitment to quality, professionalism and patient-centred care.
Our mission is simple: to connect innovative medical technologies with healthcare professionals and provide the clinical and technical support required to translate innovation into meaningful improvements in patient care.
For more information, please visit www.perfusionsvcs.com
We are a global leader focused on reducing vascular-related complications through world-class solutions designed to equally benefit clinicians and patients. Our goal is to provide intuitive products and consultative programs that improve procedural efficiencies, patient outcomes, and healthcare economic value to advance care in Vascular Access.
For more information, please visit www.teleflex.com
| Time | 13:30 – 17:00 (GMT+8) | |||
| Venue | Grand Hyatt Singapore, Residence 5, Level 3 | |||
| Format | Interactive, case-based multidisciplinary workshop focused on precision lung cancer care, integrating molecular tumour board discussions, real-world case simulations, and live audience polling. | |||
| Introduction | This workshop focuses on the practical application of molecular profiling in lung cancer, including NGS, liquid biopsy, and minimal residual disease (MRD). Emphasis is placed on translating biomarker data into real-world clinical decision-making across early-stage and advanced disease settings. | |||
| Objectives | – Apply NGS and molecular profiling in lung cancer management
– Interpret ctDNA and MRD results in clinical practice – Integrate biomarker data into treatment decisions – Manage early and advanced NSCLC using precision oncology approaches – Conduct multidisciplinary tumour board (MTB)–style decision-making in clinical scenarios – Discuss real-world challenges in implementing molecular diagnostics in routine practice – Evaluate emerging roles of perioperative and adjuvant biomarker-guided therapies |
|||
| Target Participants | Medical oncologists, thoracic surgeons, pulmonologists, pathologists, radiation oncologists, trainees, and allied health professionals. | |||
| Participants Number | 50 pax | |||
| Lead Faculty | Aaron Tan | |||
| Faculty | Jens Samol
Ramaswamy Govindan Tim Benepal |
|||
| Registration | This Workshop is available as an add-on to the Main Congress. Click here to register. | |||
Programme
| Time | Agenda | Faculty |
| 13:00 – 15:00 | Session 1 | Chairperson: Aaron Tan, Singapore |
| 13:00 – 13:20 | Evolving role of Comprehensive Genomic Profiling in Precision Oncology | Jennifer Leong, Malaysia |
| 13:20 – 13:40 | Catch me if you can: Added value of RNA | Ramaswamy Govindan, United States |
| 13:40 – 14:00 | Unlocking the Power of Liquid Biopsy | Rogelio Velasco Jr., Philippines |
| 14:00 – 14:30 | Q&A | All Faculty |
| 14:30 – 15:00 | Coffee/Tea Break | |
| 15:00 – 16:30 | Session 2 | Chairperson: Tim Benepal, United Kingdom |
| 15:00 – 15:20 | Navigating the CGP Clinical Report | Aaron Tan, Singapore |
| 15:20 – 15:40 | The Molecular Tumor Board: Translating Genomic Data into Clinical Action | Faye Zhu, Singapore |
| 15:40 – 16:00 | Molecular Residual Disease (MRD): The Next Frontier in Cancer Monitoring |
Jens Samol, Malaysia |
| 16:00 – 16:30 | Q&A | All Faculty |
Roche is a healthcare company uniquely placed to prevent, stop and cure diseases by uniting leading science and technology across diagnostics, medicines and digital solutions. The company was founded in Basel, Switzerland in 1896 and today is a leading provider of transformative medicines and diagnostics for millions of people in over 100 countries around the world.
Foundation Medicine, a subsidiary of Roche Group, is a pioneer in molecular profiling for cancer, working to shape the future of clinical care and research. We collaborate with a broad range of partners across the cancer community and strive to set the standard for quality, scientific excellence, and regulatory leadership. Our deep understanding of cancer biology helps physicians make informed treatment decisions for their patients and empowers researchers to develop new medicines.
For more information, please visit www.roche.com.sg
| Time | 08:30 – 16:30 (GMT+8) | |||
| Venue | Grand Hyatt Singapore, Grand Ballroom, Level 3 | |||
| Introduction | Explore the evolving field of robotic thoracic surgery – from multiportal and uniportal lung resections to complex mediastinal procedures and intraoperative challenges. Learn from leading international experts through surgical demonstrations, technical discussions and complex case – based sessions, while gaining practical insights into training, workflow, credentialing and building a sustainable robotic thoracic surgery programme in Asia. | |||
| Participants Number | More Information Coming Soon! | |||
| Course Directors |
Aneez Ahmed
Singapore Christopher Cao
Australia |
|||
| Chairpersons |
Cheng Hon Yap
Australia Chung-Ping Hsu
Taiwan George Karimundakcal
India Joong Na Kwon
Republic of Korea Li Yue
Singapore Lowell Leow
Singapore Padungkiat Tangpiroontham
Thailand Sabita Jiwnani
India Sivakumar Krishnasamy
Malaysia Srikishna SV
India Suparauk Geanphun
Thailand |
|||
| Faculty |
Abbas E Abbas
United States Akif Turna
Türkiye Bin Zheng
China Edmund Empaces Villaroman
Philippines Franca Melfi
Italy Gavin Wright
Australia Hasan Batirel
Türkiye Hisashi Saji
Japan Kim Hyun Koo
Republic of Korea Korkut Bostanci
Türkiye Mariko Fukui
Japan Seong Yong Park
Republic of Korea Shinichi Toyooka
Japan Young Ho Yang
Republic of Korea Yin Kai Chao
Taiwan |
|||
| Cost per pax | SGD 500 / USD 400 | |||
| Registration | This Workshop is available as an add-on to the Main Congress. Click here to register. | |||
Programme
| Time | Agenda | Faculty |
| 08:30 – 10:00 | Session 1: Multiportal Robotic Lung Resection | Chairpersons: Padungkiat Tangpiroontham, Thailand | George Karimundakcal, India | Chung-Ping Hsu, Taiwan |
| 08:30 – 08:42 | Operating Room Setup, Port Placement and Robotic Docking for Multiportal Lung Resection | Cynthia Chia Ming Li, Singapore |
| 08:42 – 08:54 | Multiportal Robotic Lobectomy: A Step-by-Step Standardised Technique |
Chun Chen, China |
| 08:54 – 09:06 | Robotic Segmentectomy: 3D Planning, Intersegmental Planes and Margin Control | Gavin Wright, Australia |
| 09:06 – 09:18 | Complex Lung Resections: Sleeve, Bilobectomy and Extended Robotic Procedures |
Abbas E Abbas, United States |
| 09:18 – 09:30 | Systematic Robotic Lymph-Node Dissection: Achieving Oncological Completeness | George Karimundakcal, India |
| 09:30 – 09:42 | Managing Bleeding and Intraoperative Emergencies During Multiportal Robotic Surgery | Franca Melfi, Italy |
| 09:42 – 10:00 | [Panel Discussion] Pulmonary Artery Injury During Robotic Upper Lobectomy | Chung-Ping Hsu, Taiwan |
| 10:00 – 10:30 | Coffee/Tea Break | |
| 10:30 – 12:00 | Session 2: Uniportal Robotic Lung Resection |
Chairpersons: Suparauk Geanphun, Thailand | Cynthia Chia Ming Li, Singapore | Adli Azam B in Mohammad Razi |
| 10:30 – 10:42 | Why Uniportal Robotics? Evolution, Potential Advantages and Current Limitations |
Korkut Bostanci, Türkiye |
| 10:42 – 10:54 | Incision, Instrument Configuration, Docking and Collision Avoidance | Yin Kai Chao, Taiwan |
| 10:54 – 11:06 | Uniportal Robotic Lobectomy: Standardised Operative Steps | Yin Kai Chao, Taiwan |
| 11:06 – 11:18 | Uniportal Robotic Segmentectomy: Planning and Technical Execution | Bin Zheng, China |
| 11:18 – 11:30 | Advanced Uniportal Robotic Lung Resection: Sleeve and Complex Procedures |
Kim Hyun Koo, Republic of Korea |
| 11:30 – 11:42 | Robot Assisted Lung Resection with a Peri-areoloar Assistant Port: Initial Experience | Linyou Zhang, China |
| 11:42 – 12:00 | [Panel Discussion] Learning Curve, Training Pathway and Safe Transition to Uniportal Robotics | All Faculty |
| 12:00 – 13:00 | Lunch Break | |
| 13:00 – 14:30 | Session 3: Multiportal and Uniportal Robotic Mediastinal Resection | Chairpersons: Sabita Jiwnani, India | Li Yue, Singapore | Franca Melfi, Italy |
| 13:00 – 13:12 | Robotic Mediastinal Surgery: Patient Selection, Imaging and Approach Planning |
Seong Yong Park, Republic of Korea |
| 13:12 – 13:24 | Multiportal Robotic Thymectomy: Technique and Anatomical Landmarks | Young Ho Yang, Republic of Korea |
| 13:24 – 13:36 | Subxiphoid and Uniportal Robotic Thymectomy: Technical Principles | Yin Kai Chao, Taiwan |
| 13:36 – 13:48 | Robotic Resection of Posterior Mediastinal and Neurogenic Tumours | Hisashi Saji, Japan |
| 13:48 – 14:00 | Complex Mediastinal Resections: Great Vessels, Pericardium and Phrenic Nerve |
Abbas E Abbas, United States |
| 14:00 – 14:12 | Oncological Outcomes and Approach Selection: Multiportal, Uniportal or Open Surgery? | Sabita Jiwnani, India |
| 14:12 – 14:30 | [Panel Discussion] Difficult Mediastinal Cases, Vascular Control and Conversion Strategies | All Faculty |
| 14:30 – 15:00 | Coffee/Tea Break | |
| 15:00 – 16:30 | Session 4: Constructing a Successful Robotic Thoracic Surgery Programme | Chairpersons: Balasubramoniam K R, India | Lowell Leow, Singapore | Sivakumar Krishnasamy |
| 15:00 – 15:10 | The Business Case: Institutional Need, Market Analysis and Strategic Positioning | Christopher Cao, Australia |
| 15:10 – 15:20 | Understanding the Economics: Capital Cost, Consumables, Maintenance and Case Volume | Edmund Empaces Villaroman, Philippines |
| 15:20 – 15:30 | Building the Robotic Team: Surgeon, Anaesthesia, Nursing and Technical Support | Franca Melfi, Italy |
| 15:30 – 15:40 | Credentialing, Proctoring and Competency-Based Training Pathways | Aneez Ahmed, Singapore |
| 15:40 – 15:50 | Improving Efficiency: Case Selection, Operating Room Workflow and Turnaround Time | Mariko Fukui, Japan |
| 15:50 – 16:00 | Governance and Growth: Outcomes Registry, Quality Assurance, Marketing and Expansion | Shinichi Toyooka, Japan |
| 16:00 – 16:30 | Designing a Sustainable Robotic Programme for Asia | All Faculty |
Since 1992, Device Technologies has been dedicated to improving patients lives through leading edge technology and services.
Successfully supplying hospitals and healthcare professionals with the finest medical solutions for their patients, Device Technologies continues to grow, with over 200 trusted brands and 850 highly skilled staff Australia and New Zealand-wide. Since 2019, Device Technologies has expanded its footprint into Asia, establishing offices in Singapore, Malaysia, Thailand, Vietnam, Philippines and Indonesia.
Leading the way in the medical technology field, Device Technologies provides the highest calibre of medical supplies with innovation and client care at the core of its values. All products distributed by Device Technologies are compliant with quality regulatory requirements, with in-servicing and ongoing support provided as part of the trusted partnership between Device Technologies staff and healthcare professionals.
For more information, please visit www.devicetechnologies.asia
At Johnson & Johnson we believe good health is the foundation of vibrant lives, thriving communities and forward progress. We strive to not only innovate across MedTech and Innovative Medicine but to improve access and affordability to lifesaving and life-enhancing treatments and medical solutions around the world. We are able to do this because for more than 80 years, our commitment to helping people has been built into our mission statement and purpose.
For more information, visit us at www.jnj.com
